BioCatalyst

APG-157 — catalyst calendar

2 verified catalyst event(s) referencing APG-157, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
Safety and Efficacy of APG-157 in Head and Neck Cancer
Phase 2 · Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity
 Aveta Biomics, Inc. APG-157 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizu
Phase 1/2 · Glioma, Glioblastoma Multiforme
 Aveta Biomics, Inc. APG-157 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.